Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR)
20mins delayed
Movement
1 Year Return
Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $84.67 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
IMR Statistics
23 January
891 / 2,294
ASX Size Rank
1yr Return
vs Sector (1yr)
-71.71%
vs ASX 200 (1yr)
-46.47%
$84.67 million
Market Cap
Share Issue
78.04 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
23 January
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Imricor Medical Systems Inc (IMR) is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The Company's primary product offering, the Vision-MR Ablation Catheter is specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters.
Upcoming Calendar
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
IMR is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr Peter McGregor | Non-Executive Director | May 2019 |
|
| Ms Doris Engibous | Non-Executive Director | Apr 2019 |
|
| Mr Steve Wedan | Chief Executive Officer, President, Executive Chairman, Executive Director | May 2006 |
|
| Mr Mark Tibbles | Non-Executive Director | Sep 2014 |
|
Director Transactions
IMR directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 31/12/19 | Steve Wedan | Issued | 501 | $1.194 | $598 | Conversion of convertible notes. |
| 31/12/19 | Steve Wedan | Transfer | 2,518,219 | $1.195 | $3,009,271 | Off-market transfer. |
| 31/12/19 | Mark Tibbles | Issued | 2,897 | $1.195 | $3,461 | Conversion of convertible notes. |
| 24/12/19 | Mark Tibbles | Exercise | 30,000 | $0.341 | $10,230 | Exercise of options. |
| 24/12/19 | Mark Tibbles | Buy | +30,000 | $0.341 | $10,230 | Exercise of options. |
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Siemens Medical Solutions USA | 8,761,342 | 9.43% |
| Warren G Herreid II | 7,680,486 | 8.26% |
| Mark A Tibbles | 4,548,981 | 4.89% |
| J P Morgan Nominees Australia Pty Limited | 3,820,819 | 4.11% |
| Khar Foundation | 2,814,002 | 3.03% |
| National Nominees Limited | 2,740,963 | 2.95% |
| Merrill Lynch (Australia) Nominees Pty Ltd |
2,680,573 | 2.88% |
| Steven R Wedan | 2,518,219 | 2.71% |
| Albert C Lardo & Jennifer S Lardo | 2,400,000 | 2.58% |
| Bauer Private Equity Fund VI | 1,696,555 | 1.83% |
| Merrill Lynch (Australia) Nominees Pty Limited | 1,691,229 | 1.82% |
| Steven R Wedan & Cherri J Wedan JT Ten | 1,427,373 | 1.54% |
| Pensco Trust Company Llc (i) | 1,187,289 | 1.28% |
| Ramsey & Co | 1,057,349 | 1.14% |
| James Dobchuk | 967,004 | 1.04% |
| HSBC Custody Nominees (Australia) Limited | 963,695 | 1.04% |
| NF Technology Holdings Ag | 959,800 | 1.03% |
| Fleitman Koppa Investments Llc | 901,530 | 0.97% |
| Pensco Trust Company Llc (ii) | 865,876 | 0.93% |
| Pershing Australia Nominees Pty Ltd |
829,472 | 0.89% |
| All other shareholders | 45.65 % | |
The Top 20 Shareholders of IMR hold 54.35% of shares on issue.
IMR Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
IMR Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Development of MRI-compatible medical devices to carry out MRI-guided cardiac catheter ablation procedures.
Incorporated: --
400 Gateway Bvd
Burnsville Minnesot USA 55337
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.